These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8519051)

  • 1. Effectiveness of clinical pharmacist interventions in a hemodialysis unit.
    Tang I; Vrahnos D; Hatoum H; Lau A
    Clin Ther; 1993; 15(2):459-64; discussion 432. PubMed ID: 8519051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist.
    Grabe DW; Low CL; Bailie GR; Eisele G
    Clin Nephrol; 1997 Feb; 47(2):117-21. PubMed ID: 9049460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient care contributions of clinical pharmacists in four ambulatory care clinics.
    Hatoum HT; Witte KW; Hutchinson RA
    Hosp Pharm; 1992 Mar; 27(3):203-6, 208-9. PubMed ID: 10116720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS; Al-Agil AA; Asiri YA; Al-Kholi TA; Akhras NS; Horanieh BK
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit.
    Miyagawa CI; Rivera JO
    Am J Hosp Pharm; 1986 Dec; 43(12):3008-13. PubMed ID: 3812508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
    Weant KA; Armitstead JA; Ladha AM; Sasaki-Adams D; Hadar EJ; Ewend MG
    Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Documenting concurrent clinical pharmacy interventions.
    Haslett TM; Kay BG; Weissfellner H
    Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical pharmacist in internal medicine--impact on the quality of therapeutic care].
    Hammerman A; Rotem R; Meidan N; Porath A
    Harefuah; 1999 Jun; 136(11):862-4. PubMed ID: 10955131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit.
    Katona BG; Ayd PR; Walters JK; Caspi M; Finkelstein BW
    Am J Hosp Pharm; 1989 Jun; 46(6):1179-82. PubMed ID: 2750769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
    Schwartzberg E; Livny S; Sterenberg A; Troitsa A; Oren M; Shani S
    Harefuah; 2003 Jan; 142(1):5-9, 80. PubMed ID: 12647481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome.
    O'Dell KM; Kucukarslan SN
    Ann Pharmacother; 2005 Sep; 39(9):1423-7. PubMed ID: 16046491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing whether a clinical pharmacy program is meeting its goals.
    Fink A; Kosecoff J; Oppenheimer PR; Smith WE; Brodie DC
    Am J Hosp Pharm; 1982 May; 39(5):806-10. PubMed ID: 7081251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
    Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
    Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
    Brown J; Josephson M
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability to justify a part-time clinical pharmacist in a community hospital intensive-care unit.
    Rosenbaum CL; Fant WK; Miyagawa CI; Armitstead JA
    Am J Hosp Pharm; 1991 Oct; 48(10):2154-7. PubMed ID: 1781471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.